AbbVie Inc.
AbbVie Inc. 0QCV.L Peers
See (0QCV.L) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0QCV.L | $146.95 | N/A | 221.05B | 21.08 | $6.97 | +4.34% |
| 0QAH.L | $89.70 | N/A | 208.46B | 13.04 | $6.88 | +3.90% |
| 0QQ6.L | $267.60 | -3.53% | 200.94B | 16.52 | $16.20 | +3.70% |
| AZN.L | $10,272.00 | +0.31% | 159.28B | 27.61 | $3.72 | +1.43% |
| 0R1F.L | $72.70 | N/A | 118.66B | 25.75 | $2.82 | +3.36% |
| GSK.L | $1,399.50 | +1.60% | 56.71B | 18.41 | $0.76 | +4.36% |
| DPH.L | $3,866.00 | +0.05% | 4.40B | -154.64 | -$0.25 | N/A |
Stock Comparison
0QCV.L vs 0QAH.L Comparison
0QCV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QCV.L stands at 221.05B. In comparison, 0QAH.L has a market cap of 208.46B. Regarding current trading prices, 0QCV.L is priced at $146.95, while 0QAH.L trades at $89.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QCV.L currently has a P/E ratio of 21.08, whereas 0QAH.L's P/E ratio is 13.04. In terms of profitability, 0QCV.L's ROE is +0.40%, compared to 0QAH.L's ROE of +0.38%. Regarding short-term risk, 0QCV.L is less volatile compared to 0QAH.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0QCV.L.